Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CSF-3

K-Number: K221260 · 2023-01-06

ApplicantCardiacsense
Decision Date2023-01-06
Product CodeDPS
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CSF-3 is a medical device manufactured by Cardiacsense. It received FDA 510(k) clearance on 2023-01-06 under approval number K221260. The device is classified under product code DPS. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CSF-3?

CSF-3 is a medical device that received FDA 510(k) clearance on 2023-01-06. It is manufactured by Cardiacsense. The 510(k) number is K221260.

When was CSF-3 approved by the FDA?

CSF-3 received FDA 510(k) clearance on 2023-01-06, under approval number K221260.

What company makes CSF-3?

CSF-3 is manufactured by Cardiacsense.

What is the FDA product code for CSF-3?

The FDA product code for CSF-3 is DPS.

Other Devices by Cardiacsense

Related Devices (Code: DPS)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.